1. Home
  2. PRTA vs IMXI Comparison

PRTA vs IMXI Comparison

Compare PRTA & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • IMXI
  • Stock Information
  • Founded
  • PRTA 2012
  • IMXI 1994
  • Country
  • PRTA Ireland
  • IMXI United States
  • Employees
  • PRTA N/A
  • IMXI N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • PRTA Health Care
  • IMXI Technology
  • Exchange
  • PRTA Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • PRTA 472.1M
  • IMXI 438.1M
  • IPO Year
  • PRTA N/A
  • IMXI N/A
  • Fundamental
  • Price
  • PRTA $10.45
  • IMXI $15.11
  • Analyst Decision
  • PRTA Buy
  • IMXI Buy
  • Analyst Count
  • PRTA 9
  • IMXI 5
  • Target Price
  • PRTA $17.71
  • IMXI $19.60
  • AVG Volume (30 Days)
  • PRTA 567.7K
  • IMXI 331.8K
  • Earning Date
  • PRTA 11-06-2025
  • IMXI 11-11-2025
  • Dividend Yield
  • PRTA N/A
  • IMXI N/A
  • EPS Growth
  • PRTA N/A
  • IMXI N/A
  • EPS
  • PRTA N/A
  • IMXI 1.65
  • Revenue
  • PRTA $11,786,000.00
  • IMXI $642,149,000.00
  • Revenue This Year
  • PRTA N/A
  • IMXI N/A
  • Revenue Next Year
  • PRTA $672.02
  • IMXI $1.87
  • P/E Ratio
  • PRTA N/A
  • IMXI $9.20
  • Revenue Growth
  • PRTA N/A
  • IMXI N/A
  • 52 Week Low
  • PRTA $4.32
  • IMXI $8.58
  • 52 Week High
  • PRTA $18.65
  • IMXI $22.37
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 56.63
  • IMXI 70.95
  • Support Level
  • PRTA $10.02
  • IMXI $14.81
  • Resistance Level
  • PRTA $11.17
  • IMXI $14.99
  • Average True Range (ATR)
  • PRTA 0.56
  • IMXI 0.07
  • MACD
  • PRTA -0.07
  • IMXI -0.00
  • Stochastic Oscillator
  • PRTA 37.37
  • IMXI 95.40

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: